Omnix Medical Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 17

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 12

Omnix Medical General Information

Description

Developer of biopharmaceutical technology designed to combat drug-resistant bacterial infections. The company's platform develops next-generation antimicrobial peptides with enhanced stability, selectivity, and a novel mechanism of action that avoids resistance development, enabling healthcare providers to effectively treat resistant bacterial strains and improve patient outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • High-Tech Village
  • Givat Ram Campus
  • Jerusalem 9270401
  • Israel
+972
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • High-Tech Village
  • Givat Ram Campus
  • Jerusalem 9270401
  • Israel
+972

Omnix Medical Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Omnix Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Secondary Transaction - Private 01-May-2026 Completed Clinical Trials - Phase 2
9. Later Stage VC (Series C) 15-Oct-2025 Completed Clinical Trials - Phase 2
8. Accelerator/Incubator Completed Clinical Trials - Phase 2
7. Later Stage VC 31-Jan-2024 Cancelled Clinical Trials - Phase 2
6. Grant 28-Feb-2023 Completed Clinical Trials - General
5. Grant 07-Oct-2020 Completed Clinical Trials - General
4. Later Stage VC (Series B) 03-Nov-2020 Completed Clinical Trials - General
3. Early Stage VC (Series A) 01-Dec-2018 Completed Clinical Trials - General
2. Grant Completed Startup
1. Accelerator/Incubator Completed Startup
To view Omnix Medical’s complete valuation and funding history, request access »

Omnix Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preferred A1
Preferred A
To view Omnix Medical’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Omnix Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biopharmaceutical technology designed to combat drug-resistant bacterial infections. The company's platform
Other Pharmaceuticals and Biotechnology
Jerusalem, Israel
17 As of 2025

Parsippany, NJ
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Omnix Medical Competitors (3)

One of Omnix Medical’s 3 competitors is Melinta Therapeutics, a Private Equity-Backed company based in Parsippany, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Melinta Therapeutics Private Equity-Backed Parsippany, NJ
Spero Therapeutics Formerly VC-backed Cambridge, MA
Roche Corporation Basel, Switzerland
You’re viewing 3 of 3 competitors. Get the full list »

Omnix Medical Patents

Omnix Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023296846-A1 Novel peptide for treating an infectious disease or condition Pending 29-Jun-2022
EP-4547696-A1 Novel peptide for treating an infectious disease or condition Pending 29-Jun-2022
EP-4547696-A4 Novel peptide for treating an infectious disease or condition Pending 29-Jun-2022
EP-4547697-A1 Novel peptide for treating an infectious disease or condition Pending 29-Jun-2022
EP-4547697-A4 Novel peptide for treating an infectious disease or condition Pending 29-Jun-2022 C07K14/463
To view Omnix Medical’s complete patent history, request access »

Omnix Medical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Omnix Medical Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Harel Insurance Investments & Financial Services Asset Manager Minority
Oriella Limited Corporation Minority
OurCrowd Venture Capital Minority
Prevail Partners Venture Capital Minority
Entrée Capital Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Omnix Medical FAQs

  • When was Omnix Medical founded?

    Omnix Medical was founded in 2015.

  • Where is Omnix Medical headquartered?

    Omnix Medical is headquartered in Jerusalem, Israel.

  • What is the size of Omnix Medical?

    Omnix Medical has 17 total employees.

  • What industry is Omnix Medical in?

    Omnix Medical’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Omnix Medical a private or public company?

    Omnix Medical is a Private company.

  • What is Omnix Medical’s current revenue?

    The current revenue for Omnix Medical is .

  • How much funding has Omnix Medical raised over time?

    Omnix Medical has raised $36.3M.

  • Who are Omnix Medical’s investors?

    Harel Insurance Investments & Financial Services, Oriella Limited, OurCrowd, Prevail Partners, and Entrée Capital are 5 of 12 investors who have invested in Omnix Medical.

  • Who are Omnix Medical’s competitors?

    Melinta Therapeutics, Spero Therapeutics, and Roche are competitors of Omnix Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process